Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel
Neha Papneja(McGill University), Shahid Ahmed(Emory University), Haji Chalchal, Mike Moser(Roswell Park Comprehensive Cancer Center), John M. Shaw(University of Saskatchewan), Kiat Tsong Tan(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Adnan Zaidi(University of Saskatchewan), Colleen Olson(Saskatchewan Cancer Agency)
Cited by 49
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia
|New England Journal of Medicine|1977|299
The Genotype-Tissue Expression (GTEx) project
|Nature Genetics|2013|266